Australia vs Côte d'Ivoire: New cases tested for RR-/MDR-TB
Australia
86.0%
in 2024
Côte d'Ivoire
86.0%
in 2024
Australia rank
115th
Côte d'Ivoire rank
115th
New cases tested for RR-/MDR-TB over time
- Australia
- Côte d'Ivoire
How they compare
Australia currently reports 86.0% against 86.0% in Côte d'Ivoire, a difference of 0.0%.
The two have swapped places 1 time across 14 shared years of data; in 2010 it was Australia ahead.
Australia ranks 115th and Côte d'Ivoire ranks 115th of 192 countries.
Australia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Australia | Côte d'Ivoire | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 98.2% | 11.7% | 86.5% | Australia |
| 2020s | 86.2% | 57.2% | 29.0% | Australia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Australia or Côte d'Ivoire?
- Australia, at 86.0% against 86.0% in Côte d'Ivoire as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Australia and Côte d'Ivoire?
- 0.0%, with Australia ahead.
- How many years of comparable data are there for Australia and Côte d'Ivoire?
- 14 years are reported by both, from 2010 to 2024.
- How do Australia and Côte d'Ivoire rank globally for new cases tested for rr-/mdr-tb?
- Australia ranks 115th and Côte d'Ivoire ranks 115th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.